Wednesday, August 24, 2016 9:13:47 AM
15 hours 18 minutes ago - DJNF
OraSure Technologies Inc. said Tuesday that it had been awarded a U.S. government contract to speed the development of its oral test kits for the Zika virus.
The Bethlehem, Pa., maker of oral tests for HIV and Ebola said the six-year contract was for upward of $16.6 million with a biomedical research agency attached to the U.S. Department of Health and Human Services.
The initial commitment is for $7 million with options of up to $9.6 million to finance evaluation of further product enhancements, and clinical and regulatory services, OraSure said.
"We believe the availability of an accurate rapid Zika antibody test will be a valuable tool to address current and potential future outbreaks," said Douglas A. Michels, OraSure's chief executive. "[The funding] will enable us to complete clinical and other activities required to obtain regulatory approvals for this product."
OraSure said it would provide an update on guidance and timing during its November earnings call. Shares of the company rose 9.3% in after-hours trading.
The company's test kits for HIV and Ebola use mouth swabs to collect saliva. Orasure claimed its tests for Zika will be of greater use than the examination of tissue or blood samples because the virus can be detected earlier with its technique.
The Zika virus, identified in Uganda in 1947, has spread in Latin America since its 2014 arrival in Brazil before making its way north. The virus has been spreading in Florida.
According to the U.S. Centers for Disease Control and Prevention, as of Aug. 11 there were 529 cases of pregnant women possibly infected with the Zika virus, which can infect a fetus, possibly causing birth defects including microcephaly, an abnormally small head associated with improper brain development.
DUKE BASKETBALL and NOTRE DAME FOOTBALL
Recent OSUR News
- OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 09:12:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:30:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:29:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:29:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:10:16 PM
- OraSure Reports Q4 ‘23 Revenue of $75.9 Million • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th • GlobeNewswire Inc. • 02/13/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:09:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:08:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:04:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:02:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:08:57 PM
- OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company • GlobeNewswire Inc. • 01/04/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:34:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 09:04:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/19/2023 09:22:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:17:59 PM
- OraSure to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/13/2023 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 09:02:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:11:39 PM
- OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year • GlobeNewswire Inc. • 11/07/2023 09:05:00 PM
- OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th • GlobeNewswire Inc. • 10/23/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 08:21:15 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM